FREE education session for families and friends, delivering useful information and strategies to those supporting someone using alcohol and other drugs. Stepping Forward aims to increase people's confidence and competence in managing alcohol and other drug issues. √ Clear & practical information sessions √ A safe place to share & to feel supported Please join […]

Presenter: Robert Fullerton, PhD By the end of this webinar, participants will gain: An understanding of Transtheoretical Model of Change; An awareness of what Motivational Interviewing is and when it is useful; Knowledge of the spirit and principles of Motivational Interviewing; An understanding of the core communication skills of Motivational Interviewing that lead to behaviour […]

Relapse prevention is about building the capacity of individuals to maintain and sustain positive changes with their substance use. This Zoom workshop is designed for practitioners who provide direct support to people with AOD concerns who wish to better understand and communicate strategies, tools and techniques that can help someone stay in recovery through the […]

Assessing and managing withdrawal is one of the core components of alcohol and other drug treatment.  This course provides an overview of the assessment and management of withdrawal for people who are dependent on alcohol and other drugs as outlined in the Queensland Alcohol and Drug Withdrawal Clinical Practice Guidelines.  Covering the five main substances […]

Whilst opioids can be very effective in treating pain, prolonged and/or heavy use can cause hyperalgesia – a phenomenon in which people become hypersensitive to painful stimuli. This talk will explore the relationship between persistent pain and opioid use disorder, and the signs and symptoms that might indicate the best treatment pathway forward. Dr Ian […]

Shared decision making is the foundation of modern patient-centred care and is key to overcoming patient- and clinical-level barriers to opiate agonist therapy (OAT) uptake and retention in treatment. Newly available depot buprenorphine products offer expanded choice in treatment modality. However, as the effectiveness and cost-effectiveness of policy decisions may be compromised by patient preferences, […]